Benzinga · Mar 5, 2026
Benchmark Upgrades Cross Country Healthcare to Buy, Announces $14 Price Target
Benchmark analyst Bill Sutherland upgrades Cross Country Healthcare (NASDAQ:CCRN) from Hold to Buy and announces $14 price target.
NASDAQ · CCRN
Healthcare · Medical - Care Facilities
$13.25
Up+$0.00 (+0.00%)
Updated Aug 15, 2026, 10:36 AM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 2 trading sessions · Daily adjusted prices
CCRN closed at $13.25 after 2 trading sessions, up 0.08% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 20, 2026 | $13.25 | $13.26 | $13.24 | $13.25 | 2.33M |
| Jul 17, 2026 | $13.25 | $13.25 | $13.224 | $13.24 | 2.81M |
The latest Smart Investors Daily articles mentioning CCRN.
CCRN research
Company profile and research snapshot.
Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jun 8, 2026 | Barrington Research | Market Perform | — |
| May 11, 2026 | Truist Securities | Hold | — |
| May 8, 2026 | Benchmark | Hold | — |
| May 7, 2026 | Wedbush | Neutral | — |
| Mar 19, 2026 | Wedbush | Outperform | — |
No generated briefing is available yet.
Benzinga · Mar 5, 2026
Benchmark analyst Bill Sutherland upgrades Cross Country Healthcare (NASDAQ:CCRN) from Hold to Buy and announces $14 price target.
Benzinga · Mar 5, 2026
ChartMill · Mar 4, 2026
Cross Country Healthcare posts Q4 loss and revenue miss, shares drop sharply. The staffing firm faces a tough market and provides weak Q1 guidance.
SeekingAlpha · Mar 4, 2026
Cross Country Healthcare, Inc. (CCRN) Q4 2025 Earnings Call March 4, 2026 5:00 PM ESTCompany ParticipantsJoshua Vogel - Vice President of Investor...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning CCRN.